Circ5379-6, a circular form of tumor suppressor

Ning Zhang, Guohua Li, Xiaoxing Li, Lixia Xu, Minhu Chen

Open access · greenAbstract read

In one paragraph

Article in American journal of translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it

0cells of the map it votes in

6citing papers in PubMed

0.6field-weighted citation impact, top 33% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway.International journal of oncology · 2024
Article
Circ_0004354 might compete with circ_0040039 to induce NPCs death and inflammatory response by targeting miR-345-3p-FAF1/TP73 axis in intervertebral disc degeneration.Oxidative medicine and cellular longevity · 2022
Article
Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.Frontiers in oncology · 2021
Review
Emerging role of circular RNA in intervertebral disc degeneration: Knowns and unknowns (Review).Molecular medicine reports · 2020
Review
Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role.Critical reviews in oncology/hematology · 2020
Review
Circular RNA circSCAF11 Accelerates the Glioma Tumorigenesis through the miR-421/SP1/VEGFA Axis.Molecular therapy. Nucleic acids · 2019
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ning ZhangDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University Guangzhou 510080, China.

Guohua LiDepartment of Gastroenterology, Shunde People's Hospital, Nanfang Medical University Foshan 528300, China.

Xiaoxing LiState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center Guangzhou 510080, China.

Lixia XuDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University Guangzhou 510080, China.

Minhu ChenDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University Guangzhou 510080, China.

Sun Yat-sen University · CNThe First People's Hospital of Shunde · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the role of circRNAs encoded by

Indexed as

circular RNAHepatocellular carcinomametastasisPPARαtumorgenesis

Identifiers

PMID30662602

PMCPMC6291688

OpenAlexW2982108047

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.